GlassScriptPhysician profile
Tyler Couch
NPI 1629841440
$1,242.62
in general payments reported to CMS, 2019-2025
18 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $93.42 · 2024: $962 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221 · Consulting Fee: $21.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.07 |
| Consulting Fee | $21.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $210.39 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Novo Nordisk INC | $173.42 | 2024 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.22 | 2024 | Jardiance |
| Genentech USA, INC. | $140.98 | 2024 | Xolair |
| Glaxosmithkline, LLC. | $121.88 | 2025 | Nucala |
| Lilly USA, LLC | $86.09 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Alexion Pharmaceuticals, INC. | $59.34 | 2024 | Strensiq |
| Amgen INC. | $57.24 | 2024 | Tepezza |
| Medtronic, INC. | $39.30 | 2024 | Intellis Adaptivestim, Minimed 780g |
| Dexcom, INC. | $33.94 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $30.14 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $28.82 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $27.79 | 2024 | |
| Adma Biomanufacturing LLC | $21.55 | 2025 | |
| Esperion Therapeutics, INC. | $18.33 | 2024 | Nexletol |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $15.29 | 2024 | Signifor Lar, Isturisa |
| Pharming Healthcare, INC. | $15.12 | 2025 | Ruconest |
| Echosens North America, INC. | $13.78 | 2024 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.